Aptose Biosciences Inc  

(Public, NASDAQ:APTO)   Watch this stock  
Find more results for OTC:LRUSF
0.00 (0.00%)
Real-time:   2:11PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 3.30 - 11.19
Open     -
Vol / Avg. 0.00/698.00
Mkt cap 76.05M
P/E     -
Div/yield     -
EPS -1.88
Shares 11.61M
Beta 1.14
Inst. own     -
Oct 8, 2014
Aptose Biosciences Inc at BIO Investor Forum
Aug 13, 2014
Lorus Therapeutics Inc at Canaccord Genuity Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (May '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -87.62% -66.09%
Return on average equity -104.23% -76.31%
Employees 19 -
CDP Score - -


2 Meridian Rd
+1-416-7981200 (Phone)
+1-416-7982200 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Aptose Biosciences Inc, formerly Lorus Therapeutics Inc., is a life sciences company. The Company is focused on the discovery, research and development of effective anticancer therapies with a safety profile. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to a completed Phase I clinical trial. Intellectual property portfolio supports its diverse product pipeline.

Officers and directors

William G. Rice Ph.D. Chairman of the Board, Chief Executive Officer
Bio & Compensation  - Reuters
Gregory K. Chow Chief Financial Officer
Bio & Compensation  - Reuters
Elizabeth Williams Finance Director, IR Contact Officer
Bio & Compensation  - Reuters
Daniel D. Von Hoff M.D., Senior Vice President - Medical Affairs
Bio & Compensation  - Reuters
Yoon Lee PhD Vice President - Research
Bio & Compensation  - Reuters
Stephen B. Howell M.D. Chief Medical Officer
Age: 69
Bio & Compensation  - Reuters
Jim A. Wright Ph.D. Lead Director
Bio & Compensation  - Reuters
Denis R. Burger Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Brad Thompson Independent Director
Bio & Compensation  - Reuters
Brian J. Underdown Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters